Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Heart Valve Disease|March 25, 2015
Routine cine-CMR for prosthesis-associated mitral regurgitation: a multicenter comparison to echocardiographyLauren A Simprini, Anika Afroz, Mitchell A Cooper, et al.
Journal of Thrombosis and Thrombolysis|May 24, 2013
EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudyThomas J Povsic, Samer S Najjar, Kristi Prather, et al.
Circulation. Heart Failure|April 18, 2018
Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure TrialEldrin F Lewis, Brian Claggett, Amil M Shah, et al.
JAMA|May 12, 2011
Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trialSamer S Najjar, Sunil V Rao, Chiara Melloni, et al.
Circulation|April 9, 2017
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)Udo Hoffmann, Maros Ferencik, James E Udelson, et al.
Circulation. Heart Failure|August 15, 2014
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) TrialAmil M Shah, Brian Claggett, Nancy K Sweitzer, et al.
Journal of the American College of Radiology : JACR|December 1, 2023
ACR Appropriateness Criteria® Pulsatile Abdominal Mass, Suspected Abdominal Aortic Aneurysm: 2023 Update, David S Wang, Jody Shen, et al.
Circulation. Heart Failure|December 22, 2012
Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trialSanjiv J Shah, John F Heitner, Nancy K Sweitzer, et al.
Lancet (London, England)|June 17, 2014
Losmapimod, a novel p38 mitogen-activated protein kinase inhibitor, in non-ST-segment elevation myocardial infarction: a randomised phase 2 trialL Kristin Newby, Michael S Marber, Chiara Melloni, et al.
Circulation|November 20, 2014
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trialMarc A Pfeffer, Brian Claggett, Susan F Assmann, et al.
Pageof 9